Site Search
421 Results (showing 1 - 25)
Mar 31, 2006
NIH Publishes New Solicitation of Assays for MLSCN
The National Institutes of Health announced new deadlines for applications to participate in the Molecular Libraries and Screening Center Network, which intends to screen 100 to 200 HTS assays per year.
Mar 31, 2006
Almac Picks Rosetta Resolver Over Lower-Priced Options for Array-Based Cancer Dx Development
Premium
The agreement underscores Rosetta s strategy to move its software platform closer to the clinic in step with microarray technology. Subscribers: click headline for more
Mar 31, 2006
MDS to Wind Down Mass Spec and LC Operations in Montreal to Hasten FDA Investigation
NEWSBRIEF
Mar 31, 2006
Amnis Closes $11.3M Expanded Financing Round; Extra Cash to Drive R&D, Manufacturing, New Hires
Premium
The unexpected windfall is expected to speed further development of the company s flagship platform, the ImageStream flow-based cellular analysis system, as the company aims for placements in core flow cytometry facilities. Subscribers: click headline for more
Mar 31, 2006
Dyadic Partners With Scripps Florida to Annotate Genome of Dyadic s C1 Fungus Genome
NEWSBRIEF
Mar 31, 2006
Becton Dickinson has been awarded US Patent No. 7,016,087, "Photon-efficient scanner."
Inventors listed on the patent are David Heffelfinger, Aram Schiffman, and Bala Manian.
Mar 31, 2006
On March 16, the US Food and Drug Administration rolled out its Critical Path Opportunities List 76 projects that it expects to help set priorities for the Critical Path Initiative, which it kicked off in 2004 to help speed the drug-development process [BioInform 03-24-06
Mar 31, 2006
Computational systems biology is giving oncology research a boost at the drug maker, which is using technology from Gene Network Sciences, Ariadne Genomics, and GeneGo to elucidate the mechanism of action of potential therapeutics and point the way toward biomarkers related to drug efficacy and response. Subscribers: click headline for more
Mar 31, 2006
US Patent 7,020,561. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data. Inventors: Kevin McLoughlin, Francois Collin, Victor Markowitz, Thodoros Topaloglou, Alexandros Athanasopoulos. Assignee: Gene Logic.
Mar 31, 2006
The centerpiece for the company s revamped life science strategy is the Discovery Cluster, a pre-assembled rack based on the Sun Fire X2100 64-bit x64 server, which is powered by the AMD Opteron dual-core processor. Subscribers: click headline for more
Mar 31, 2006
ABI/MDS Sciex to Distribute ACD/Labs Software
Applied Biosystems and joint venture partner MDS Sciex will sell Advanced Chemistry Development's MS Manager, MS Fragmenter, and ChemSketch Software in combination with ABI/MDS Sciex's mass spectrometry products worldwide.
Mar 31, 2006
CompuCyte Gains New Ground in Academia, But Will Pharma Remain Interested in i Series Cytometers?
Premium
Most of CompuCyte s recent placements have been with academic laboratories or research institutes, signifying that the company s instruments have gained a foothold specifically in that market. Subscribers: click headline for more
Mar 31, 2006
For CompuCyte, CSHL User Symposium Highlights Opportunities, Marketing Challenges for Cytometer
Premium
The CSHL symposium demonstrated the wide array of application areas for which CompuCyte s newest instruments are suited, but also revealed one of the biggest challenges for the company: With so many potential markets to play in, how to focus on the most important ones? Subscribers: click headline for more
Mar 30, 2006
Ipsogen Licenses Mutation from French Institutes for Myeloproliferative Disorders
NEWSBRIEF
Mar 30, 2006
As Proteomics Gains Ground in Asia, Pall, Others Take Steps to Expand; Is Market Ready for Them?
Premium
As biotechnology facilities continue to grow in India and China, proteomics technologies have begun gaining traction there both as R&D components for drug discovery and as part of discovery research in academic centers. But is the market mature enough to justify significant investment? Subscribers: click headline for more